Advertisement

St. Jude CEO Daniel Starks says his rivals' laser-focus on cheaper medical devices for emerging markets puts too much stake in the present rather than looking to the future.

St. Jude CEO Starks snarks rivals

St. Jude Medical (NYSE:STJ) CEO Daniel Starks has his own key to success, and it doesn't jibe well with some of his rivals, who he left unnamed in his criticism.

Starks told an audience at the Minnesota Venture Finance Conference this week that excessive focus on emerging markets fails to appreciate the potential of the medical device industry.

Advertisement
Advertisement